ISRCTN41323372已完成未知
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 1,680 人开始时间: 2006年6月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,680
研究概览
简要总结
2013 results in https://www.ncbi.nlm.nih.gov/pubmed/23117245 2014 results in https://www.ncbi.nlm.nih.gov/pubmed/24667161 2015 results in https://www.ncbi.nlm.nih.gov/pubmed/24297379
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Caucasian men and women of at least 50 years of age
- •2. Primary knee osteoarthritis
- •3. Under effective contraceptive method for non-menopausal women
排除标准
- •1. Knee prosthesis already implanted or foreseen within the next year
- •2. Hip prosthesis recently implanted (<1 year) or not well-tolerated, or foreseen within the next year
研究者
相似试验
已完成
不适用
The efficacy and safety of strontium ranelate in the treatment of male osteoporosis: a prospective multicentre, international, double-blind, placebo-controlled study with a treatment duration of 2 years and the main study analysis after 1 yearMale osteoporosisMusculoskeletal DiseasesOsteoporosisISRCTN49960746Institut de Recherches Internationales Servier (France)221
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study. - POLKAMedDRA version: 7.0Level: PTClassification code 10031161OsteoarthritisEUCTR2005-002494-75-DKInstitut de Recherches Internationales Servier1,680
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.MedDRA version: 7.0Level: PTClassification code 10031161OsteoarthritisEUCTR2005-002494-75-ATInstitut de Recherches Internationales Servier1,680
进行中（未招募）
不适用
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 2 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.MedDRA version: 7.0Level: PTClassification code 10031161OsteoarthritisEUCTR2005-002494-75-EEInstitut de Recherches Internationales Servier2,118
进行中（未招募）
1 期
The efficacy and safety of two doses of strontium ranelate (1g and 2g per day) versus placebo administered orally for 3 years in the treatment of knee osteoarthritis. A prospective multicentre, international, double-blind, placebo-controlled study.MedDRA version: 7.0 Level: PT Classification code 10031161OsteoarthritisEUCTR2005-002494-75-GBServier Research and Development Ltd. (S.R.D.L) (for UK only)1,680